Daniela Rivanera
Overview
Explore the profile of Daniela Rivanera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
226
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Carradori S, Bizzarri B, DAscenzio M, De Monte C, Grande R, Rivanera D, et al.
Eur J Med Chem
. 2017 Oct;
140:274-292.
PMID: 28963991
With reference to recent studies reporting on the various biological properties of the thiazolidinone scaffold, we synthesized more than a hundred compounds characterized by a 1,3-thiazolidin-4-one nucleus derivatised at the...
2.
Rossi F, Prosperini L, De Rossi N, Capra R, Rivanera D, Li X, et al.
Viral Immunol
. 2017 Aug;
30(8):622-626.
PMID: 28836899
To determine the association between BK polyomavirus (BKPyV) types 1 and 4 capsid antibody and natalizumab-associated progressive multifocal leukoencephalopathy (PML) in patients with multiple sclerosis (MS), serum samples were obtained...
3.
Carradori S, Secci D, Bizzarri B, Chimenti P, De Monte C, Guglielmi P, et al.
J Enzyme Inhib Med Chem
. 2017 May;
32(1):746-758.
PMID: 28537532
We designed and synthesised novel N-substituted 1,3-thiazolidin-4-one derivatives for the evaluation of their anti-Toxoplasma gondii efficacy. This scaffold was functionalised both at the N1-hydrazine portion with three structurally different moieties...
4.
Secci D, Carradori S, Bizzarri B, Chimenti P, De Monte C, Mollica A, et al.
Eur J Med Chem
. 2016 Apr;
117:144-56.
PMID: 27100030
Pursuing our recent outcomes regarding the antifungal activity of N-substituted 1,3-thiazolidin-4-ones, we synthesized thirty-six new derivatives introducing aliphatic, cycloaliphatic and heteroaromatic moieties at N1-hydrazine connected with C2 position of the...
5.
Gidaro M, Alcaro S, Secci D, Rivanera D, Mollica A, Agamennone M, et al.
J Enzyme Inhib Med Chem
. 2016 Mar;
31(6):1703-6.
PMID: 26985772
Candida albicans represents the most prevalent microbial population in mucosal and systemic infections, usually confined to severely immunocompromised people. Considering the increase of resistant strains and the demand for new...
6.
De Monte C, Carradori S, Bizzarri B, Bolasco A, Caprara F, Mollica A, et al.
Eur J Med Chem
. 2015 Nov;
107:82-96.
PMID: 26562544
On the basis of the recent findings about the biological properties of thiazolidinones and taking into account the encouraging results about the antifungal activity of some (thiazol-2-yl)hydrazines, new N-substituted heterocyclic...
7.
DAscenzio M, Bizzarri B, De Monte C, Carradori S, Bolasco A, Secci D, et al.
Eur J Med Chem
. 2014 Aug;
86:17-30.
PMID: 25140751
We designed and synthesized a large number of novel thiazolidin-4-one derivatives for the evaluation of their anti-Toxoplasma gondii activity. This scaffold was functionalized at the N1-hydrazine portion with aliphatic, cycloaliphatic...
8.
Granato M, Lacconi V, Peddis M, Di Renzo L, Valia S, Rivanera D, et al.
Biochim Biophys Acta
. 2014 Apr;
1843(7):1348-55.
PMID: 24726834
Autophagy has a pivotal role in the in-vitro monocyte differentiation into macrophages and dendritic cells (DCs), the most powerful antigen presenting cells (APC) with the unique capacity to initiate an...
9.
Carradori S, Secci D, Bolasco A, Rivanera D, Mari E, Zicari A, et al.
Eur J Med Chem
. 2013 May;
65:102-11.
PMID: 23702472
Thirty-eight new (4-(4-substituted-phenyl/2,4-disubstituted-phenyl)-thiazol-2-yl)hydrazine derivatives were synthesized in good yield and assayed for their in vitro anti-Candida activity, compared to topical and systemic antifungal drugs, against twenty-two clinical isolates of Candida...
10.
Secci D, Bizzarri B, Bolasco A, Carradori S, DAscenzio M, Rivanera D, et al.
Eur J Med Chem
. 2012 May;
53:246-53.
PMID: 22560629
Novel (4-(4-iodophenyl)-thiazol-2-yl)hydrazine derivatives were assayed for their in vitro anti-Candida activity, compared to topical and systemic antifungal drugs, against twenty-seven clinical isolates. The presence of aliphatic chains or specific heteroaromatic...